US FDA

21 CFR 211.184 - Component, Container, Closure and Labeling Records

Plain-language explanation, inspection context and common violation patterns.

What it says

Records must be kept for each shipment of each lot of components, drug product containers, closures and labeling, including the identity and quantity, the supplier's name and the supplier's lot number, the date of receipt, the expiration or retest date if any, the results of testing or examination and the conclusions, and a record of the disposition, whether approved or rejected.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

What FDA inspectors look for

Most common violation

Receiving records that lack the supplier's lot number or a documented disposition decision.

Related regulations

Want a deeper, interactive breakdown?

GMPify's Regulation Explainer tool gives subscribers an AI-powered analysis of any 21 CFR, EU GMP, USP or ICH reference, with live inspection context.

Try the Regulation Explainer →